ARR, BICP and FNF have been added to the Zacks Rank #5 (Strong Sell) List on June 11, 2025.
CYBR's $1.22 billion ARR, strong subscription gains, and Secure AI Agent debut fuel its identity security momentum.
Despite unpredictable interest rates, ARR.PR.C offers a compelling yield advantage over Treasuries, currently yielding 8.56%, about 400bp above the 10Y Treasury. ARR's strong capital cushion and management's satisfaction with the fixed coupon make a near-term call of ARR.PR.C unlikely, supporting long-term income stability. Our fixed-income strategy, focused on discounted preferred equities like ARR.PR.C continues to outperform long-term bonds, even as rate predictions prove unreliable.
ON24 continues to lose customers, ARR, and revenue, with little evidence of AI-driven innovation or turnaround despite management's claims. ONTF faces intense competition from stronger players like Zoom and struggles to retain recurring revenue, with only half of ARR on multi-year contracts. Profitability is worsening, with negative adjusted EBITDA and ongoing cash burn, making ON24's low valuation a reflection of market distrust.
Downgrading Rapid7 to Hold as near-term demand remains soft and legacy segment weakness persists, despite long-term growth levers and improving execution. Q1 results were mixed: ARR grew 4% year-over-year, but legacy vulnerability management continues to decline, offsetting strong Detection & Response growth. Platform innovation, international expansion, and go-to-market optimization position Rapid7 well for the future, but macro headwinds are delaying meaningful ARR acceleration.
I recommend a hold on ARR due to its attractive dividend yield balanced by risks from interest rate uncertainty and high leverage. Dividend coverage appears adequate short-term, but discrepancies between GAAP and non-GAAP earnings raise long-term sustainability concerns. ARR's financial performance is hindered by high leverage and interest rate sensitivity, limiting growth and increasing risk in current conditions.
Holding a meaningful cash position due to buyouts, providing optionality and safety amidst macro uncertainty, with plans to invest opportunistically. Lifecore Biomedical shows promise with strengthened balance sheet, improved sales force, and potential sale within 3 years, offering significant upside. NextNav's GPS technology investment faces short-term stock weakness but has positive FCC developments and strategic refinancing, indicating long-term potential.
Armour Residential REIT (ARR) came out with quarterly earnings of $0.86 per share, missing the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.82 per share a year ago.
It's tempting to buy the dip in some of the battered REITs (Real Estate Investment Trusts) and high-yield dividend stocks, while most others flee them due to Trump's tariff concerns.
I'm downgrading Progress Software to a neutral rating, as its relative valuation against the broader market is no longer as compelling. After the company's integration of its major ShareFile acquisition, its ARR has declined sequentially, while net revenue retention rates remain low. Despite Progress' low P/E ratio and recent guidance boost, its slow organic growth and elevated debt make other software stocks more attractive buys.
Nebius grew full-year 2024 revenue by 462% to $117.5M, with Q4 AI cloud revenue up 602% year-over-year. March 2025 annualized run-rate revenue (ARR) is expected to exceed $220M, targeting $750M–$1B ARR by year-end. Trading at just 2.9x forward EV/ARR, Nebius is significantly undervalued versus AI peers trading at 20–25x multiples.
Nebius Group N.V., a leading AI infrastructure company in Europe, is attractively priced after a nearly 50% stock slump amid booming ARR growth projections. The company is well-positioned for a European boost, with significant investments in data centers across Europe and expansion plans in the U.S. Despite missing Q4 targets, Nebius reported 466% revenue growth and has ambitious ARR goals, aiming for up to $1 billion by December 2025.